J Clin Oncol 2012 May 1
Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline.
Related Questions
Does it differ in the curative vs palliative setting? Specifically thinking about adjuvant CAPOX in a patient with a BSA of 3. ~400 mg of oxaliplatin ...
New answer by Medical Oncologist at Fred Hutchinson Cancer Research Center (April 27, 2021)
Our approach to chemotherapy dosing for overweight and obese patients remains as we recommended in JCO 2012 by Griggs et al., PMID 22473167. Most overweight and obese patients...